← Open Payments lookup

AMY KUO: Open Payments

NPI 1861143752 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,655 in 43 payments from 14 companies in 2025. Trend: 2023 $444 · 2024 $1,093 · 2025 $1,655

Food & beverage: $1,655
CompanyPaymentsAmount
Syndax Pharmaceuticals, Inc.3$316
Daiichi Sankyo Inc.12$270
E.R. Squibb & Sons, L.L.C.2$254
AstraZeneca Pharmaceuticals LP10$196
Janssen Biotech, Inc.2$158
Rigel Pharmaceuticals, Inc.2$146
Merck Sharp & Dohme LLC4$116
Celgene Corporation2$34
BeOne Medicines USA, Inc.1$31
Kite Pharma, Inc.1$31

Products named: REVUFORJ, CALQUENCE, Vanflyta, OPDIVO, RYBREVANT, BREYANZI, REZLIDHIA, KEYTRUDA.

Industry payments across CA — which companies pay providers there.